Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 2984Precursor Cell Lymphoblastic Leukemia-Lymphoma 2500Lymphoma, Non-Hodgkin 2269Leukemia, Lymphocytic, Chronic, B-Cell 1992Lymphoma, Follicular 1851Lymphoma, Large B-Cell, Diffuse 1786Leukemia 1341Hodgkin Disease 1293Lymphoma, Mantle-Cell 1193Leukemia, Myeloid, Acute 979Burkitt Lymphoma 958Multiple Myeloma 867Lymphoma, B-Cell, Marginal Zone 854Recurrence 842Lymphoma, B-Cell 756Myelodysplastic Syndromes 683Neoplasms 595Lymphoma, T-Cell, Cutaneous 543Waldenstrom Macroglobulinemia 514Lymphoma, Large-Cell, Immunoblastic 490Mycosis Fungoides 438Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 415Lymphoma, Large-Cell, Anaplastic 390Sezary Syndrome 364Lymphoma, T-Cell, Peripheral 352Hematologic Neoplasms 352Leukemia, Myelogenous, Chronic, BCR-ABL Positive 334Myeloproliferative Disorders 328Neoplasms, Plasma Cell 309Blast Crisis 284

Interventions

Ascorbic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Corneal Endothelial Cell Loss × Lymphoid × Clear all
NCT06781970 2025-01-17

Effect of Vitamin C Supplementation in Corneal Endothelial Damage in Phacoemulsification of Patients with Hard Cataracts

Indonesia University

Phase NA Recruiting
120 enrolled
Lymphoid

Cataract, Corneal Endothelial Cell Loss, Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡